Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of June 7, 2025 • 8:00 AM ET
As of June 7, 2025 • 8:00 AM ET
Date/Time | Source | News Release |
---|---|---|
05/23/2025 09:13 AM EDT | Equity Insider | New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs |
05/12/2025 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Monday, May 12th, 2025 |
05/12/2025 05:31 AM EDT | US Earnings Reports | Expected earnings - TScan Therapeutics Inc. |
05/11/2025 06:48 PM EDT | KlickAnalytics | TCRX - Historical Price Movements Surrounding Earnings |
05/11/2025 06:43 PM EDT | KlickAnalytics | TCRX - Historical Earnings Price Analysis |
05/06/2025 11:13 AM EDT | SeekingAlpha | TScan Therapeutics GAAP EPS of $0.26 |
05/06/2025 08:20 AM EDT | Zacks | TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Tops Revenue Estimates |
03/07/2025 11:31 AM EST | SeekingAlpha | TScan: 2 Major Milestones Of TSC-101 To Carry Tide In 2025 |
03/05/2025 04:34 PM EST | SeekingAlpha | TScan Therapeutics files for $300M mixed securities shelf |
03/05/2025 09:10 AM EST | SeekingAlpha | TScan Therapeutics GAAP EPS of $0.30, revenue of $0.67M |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.